Between Two Benches: From corporate to entrepreneur and back…

Feb 2 2016

Healthcare entrepreneurs start companies to create solutions that ultimately benefit patients; but this is a long journey, with few road signs along the way. Join us on February 2 to hear insights and lessons learned from a successful co-founder and CMO of one of the first JLABS @ 953 "graduates", Assembly Biosciences.

Uri Lopatin, co-founder, Chief Medical Officer, and Vice President of R&D at Assembly Biosciences (ASMB) will be interviewed by Jeff Calcagno of Johnson & Johnson Innovation. The conversation will focus on the making of a healthcare entrepreneur, how he navigated his way from academia to big biotech to start up, and how he and his teammates-with help from Johnson & Johnson Innovation-led Assembly Biosciences from seed stage to public company in less than two years. The pair will be look at the highlights of Uri's journey, including early mistakes and successes, surprises, lessons learned from working with investors and with Johnson & Johnson Innovation, and more.

Don't miss the opportunity to learn from this lively and candid discussion between two individuals who are making a difference in the biotech space.

The Inspiring Leader Series provides an intimate forum for biotech veterans and experts to share their career successes and challenges. Each accomplished speaker shares lessons learned over the course of his or her professional adventure. The audience is comprised largely of entrepreneurs getting ready to embark on his or her own company-building journey. The series is an interactive and inspiring experience.

11:30am | Registration Opens, Lunch and Networking
12:00pm | Presentation, Interview and Q&A
1:00pm | Program Close

Uri Lopatin | Co-founder, Chief Medical Officer & Vice President of R&D, Assembly Biosciences read bio»
[interviewer] Jeff Calcagno | New Ventures, Johnson & Johnson Innovation read bio»

$25 | General Public
$15 | Academic/Student Rate
$35 | At the door

329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It

Speakers' biographies:

Uri Lopatin Uri Lopatin, M.D. | Co-founder, Chief Medical Officer & Vice President of R&D, Assembly Biosciences
Dr. Lopatin is a co-founder and the Chief Medical Officer and VP R&D for Assembly Pharmaceuticals, Inc. Prior to Assembly, he was a Senior Director for Clinical and Translational Research-Liver Disease at Gilead Sciences, a Translational Medical Leader at Roche, and an Associate Director at Schering Plough. He has designed and coordinated pre-clinical and clinical collaborations, as well as phase I through IV clinical studies of multiple new molecular entities. Dr. Lopatin has published extensively, especially on hepatitis B and immunology and is an author of multiple patents in the field of treatment and diagnosis for viral hepatitis. Dr. Lopatin received his infectious disease Board certification following fellowship training in ID at the NIH, and internal medicine board certification following completion of residency at NYU. He received his MD in 2000 from University of Medicine and Dentistry-New Jersey Medical School, where he was the recipient of the Stanley S Bergen medal of excellence. He holds a BA in biology from Cornell University, where he graduated cum laude with distinction in all subjects.
Connect with Uri: Connect on LinkedIn Follow on Twitter

Jeff Calcagno Jeff Calcagno, M.D. | New Ventures, Johnson & Johnson Innovation
Jeff is a senior operating and business development executive focused on healthcare innovation. He is based in Johnson & Johnson's California Innovation Center, which he helped to establish. He is a member of the New Ventures team, which is responsible for identifying promising new technologies for Johnson & Johnson (J&J), the world's largest healthcare company, and for structuring optimal business relationships. Jeff's career has spanned healthcare and business for over two decades and has included roles as a management consulting at McKinsey & Company and as a research analyst at JP Morgan H&Q. A former entrepreneur who has raised over $50MM in venture money, he ran corporate development for WIDCOMM, a technology company acquired by Broadcom, and served as CFO & CBO for Vela Pharmaceuticals, a venture-backed drug development company. From 2006 to 2010 he was a Principal & Kauffman Fellow at Scale Venture Partners, a venture fund with over $1B under management. Jeff graduated Phi Beta Kappa in Biology from Harvard College and earned an M.D. from Harvard Medical School. He completed his psychiatry residency at UCLA's Neuropsychiatric Institute and was chosen as program chief resident. Afterwards, he was awarded and completed a clinical neuropharmacology fellowship focusing on the care of treatment-refractory patients. A former Rotary International Ambassadorial Scholar, Jeff is conversational in six languages.
Connect with Jeff: Connect on LinkedIn Follow on Twitter